Reneo Pharmaceuticals Stock Quote RPHM - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

18.20

Bid

1.75

Ask

1.88

Volume

0.00 Day's Range 0.00

9.801 52 Week Range 87.40

Market Cap

608.404M

Previous Close

18.20

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

161,540

Shares Outstanding

33,428,808

Dividend Yield

PE Ratio

-7.86

Earnings Per Share (EPS)

-2.32

Revenue

Net Profit

-77.39M

Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing ... Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

reneopharma.com

Headquarters

Wilmington, Delaware, USA

Founded

Reneo Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RPHM. The last closing price for Reneo Pharmaceuticals was $18.20. Over the last year, Reneo Pharmaceuticals shares have traded in a share price range of $ 9.801 to $ 87.40.

Reneo Pharmaceuticals currently has 33,428,808 shares outstanding. The market capitalization of Reneo Pharmaceuticals is $608.40 million. Reneo Pharmaceuticals has a price to earnings ratio (PE ratio) of -7.86.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	18.2	18.2	18.2	0	0	CS
4	4.35	31.4079422383	13.85	19	12.7	267547	15.5877779	CS
12	3.4	22.972972973	14.8	19	12.501	161540	15.07808595	CS
26	1.1	6.43274853801	17.1	19.3	12.501	214727	15.80917004	CS
52	-56.2	-75.5376344086	74.4	87.4	9.801	421632	20.0472205	CS
156	-50.6	-73.5465116279	68.8	112.95	9.801	193579	30.41845117	CS
260	-134.8	-88.1045751634	153	168.3	9.801	177082	35.70991727	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
STECSantech Holdings Limited	$ 3.15 (719.03%)	9.15M
VSVersus Systems Inc	$ 1.98 (72.17%)	918.55k
BDRXBiodexa Pharmaceuticals PLC	$ 7.64 (52.50%)	557.57k
CTCXCarmell Corporation	$ 0.506 (46.37%)	10.56M
NVCRNovoCure Ltd	$ 22.40 (25.98%)	484.28k
PENGPengiun Solutions Inc	17.08 (-16.32%)	85.8k
DRCTDirect Digital Holdings Inc	$ 3.0801 (-14.20%)	10.04k
DBGIDigital Brands Group Inc	$ 0.20005 (-13.02%)	1.06M
ALRNAileron Therapeutics Inc	$ 3.21 (-13.01%)	256
JDZGJIADE Ltd	$ 0.968 (-12.79%)	376.53k
CTCXCarmell Corporation	$ 0.506 (46.37%)	10.56M
STECSantech Holdings Limited	$ 3.15 (719.03%)	9.15M
NVDANVIDIA Corporation	$ 130.67 (-0.71%)	5.8M
HAOHaoxi Health Technology Ltd	$ 0.185 (1.20%)	5.53M
GRTSGritstone bio Inc	$ 0.0674 (-1.75%)	4.61M